Systems and method are disclosed for cosmetic augmentation by forming a biocompatible cross-linked polymer having a multi-phase mixture with a predetermined controlled release of a pharmaceutical substance to modulate soft tissue response to the polymer, the polymer having at least one phase cross-linked, glycosaminoglycan in a physiological buffer solution and augmenting soft tissue with the biocompatible cross-linked polymer.
